Top

BMC Pediatrics

Published in:

Open Access 01-12-2004 | Research article

Clinical utility of antinuclear antibody tests in children

Authors: Julie L McGhee, Lauren M Kickingbird, James N Jarvis

Published in: BMC Pediatrics | Issue 1/2004

Abstract

Background

Antinuclear antibody (ANA) tests are frequently used to screen children for chronic inflammatory diseases such as systemic lupus erythematosus (SLE). However, the diagnostic utility of this test is limited because of the large number of healthy children who have low-titer positive tests. We sought to determine the clinical utility of ANA tests in screening children for rheumatic disease and to determine whether there are specific signs or symptoms that enhance the clinical utility of ANA tests in children.

Methods

We undertook a retrospective analysis of 509 new patient referrals. Charts of patients referred because of results of ANA testing were selected for further analysis. Children with JRA, SLE, and other conditions were compared using demographic data, chief complaints at the time of presentation, and ANA titers.

Results

One hundred ten patients were referred because of an ANA test interpreted as positive. Ten patients were subsequently diagnosed with SLE. In addition, we identified one patient with mixed connective tissue disease, and an additional child with idiopathic Raynaud's phenomenon. Eighteen children of the children referred for a positive ANA test had juvenile rheumatoid arthritis (JRA). Another 80 children with positive ANA tests were identified, the majority of whom (n = 39, 49%) had musculoskeletal pain syndromes. Neither the presence nor the titer of ANA served to distinguish children with JRA from children with other musculoskeletal conditions. Children with JRA were readily identified on the basis of the history and physical examination. Children with SLE were therefore compared with children with positive ANA tests who did not have JRA, designated the "comparison group." Non-urticarial rash was more common in children with SLE than in children without chronic inflammatory disease (p = 0.007). Children with SLE were also older (mean ± sd = 14.2 ± 2.5 years) than the comparison group (11.0 ± 3.6 years; p = 0.001). ANA titer was also a significant discriminator between children with SLE and children without chronic inflammatory disease. The median ANA titer in children with SLE was 1: 1,080 compared with 1:160 for other children (p < 0.0001). ANA titers of ≥1,080 had a positive predictive value for SLE of 1.0 while titers of ≤1: 360 had a negative predictive value for lupus of 0.84.

Conclusion

Age and ANA titer assist in discriminating children with SLE from children with other conditions. ANA tests are of no diagnostic utility in either making or excluding the diagnosis of JRA.

Available only for authorised users

Arkachaisri T, Lehman TJ: Systemic lupus erythematosus and related disorders of childhood. Curr Op Rheumatol. 1999, 11: 384-392. 10.1097/00002281-199909000-00010.CrossRef

Petty RE, Cassidy JT: Systemic lupus erythematosus. In: A Textbook of Pediatric Rheumatology. Edited by: Cassidy JT, Petty RE. 2001, Philadelphia: WB Saunders Co, 397-

Iqbal S, Sher MR, Good RA, Cawkwell GD: Diversity of presenting manifestations of systemic lupus erythematosus. J Pediatr. 1999, 135: 500-505.CrossRefPubMed

Cabral DA, Petty RE, Fung M, Malleson P: Persistent antinuclear antibodies in children without identifiable rheumatic or autoimmune disease. Pediatrics. 1992, 89: 441-444.PubMed

Deane PMG, Liard G, Siegel DM, Baum J: The outcome of children referred to a pediatric rheumatology clinic with a positive antinuclear antibody test but without an autoimmune disease. Pediatrics. 1995, 95: 892-895.PubMed

Malleson PN, Sailer M, Mackinnon MJ: Usefulness of antinuclear antibody testing to screen for rheumatic diseases. Arch Dis Child . 1997, 77: 299-304.CrossRefPubMedPubMedCentral

McGhee JL, Burks FN, Sheckels JL, Jarvis JN: Identifying children with chronic arthritis based on chief complaints. Absence of musculoskeletal pain as a predictor of chronic arthritis in children. Pediatrics. 2002, 110: 354-359.CrossRefPubMed

Weed LL: Quality control and the medical record. Arch Int Med. 1971, 127: 101-105. 10.1001/archinte.127.1.101.CrossRef

Weed LL: Medical records that guide and teach. N Eng J Med. 1968, 278: 593-657.CrossRef

10.

Tan EM: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982, 25: 1271-1277.CrossRefPubMed

11.

Cassidy JT, Levinson JE, Brewer EJ: The development of classification criteria for children with juvenile rheumatoid arthritis. Bull Rheum Dis. 1989, 38: 1-7.PubMed

12.

Sherry DD, Malleson PN: Nonrheumatic musculoskeletal pain. In: Textbook of Pediatric Rheumatology. Edited by: Cassidy JT, Petty RE. 2001, Philadelphia: WB Saunders Co, 362-380.

13.

Rosenberg AM: Analysis of a pediatric rheumatology clinic population. J Rheumatol. 1990, 17: 827-830.PubMed

14.

Bowyer S, Roettcher P, members of the pediatric rheumatology database research group: Pediatric rheumatology clinic populations in the United States: results from a 3 year survey. J Rheumatol. 1996, 23: 1968-1974.PubMed

15.

Jarvis JN: Mechanisms of pathogenesis and inflammation in the pediatric rheumatic diseases. Curr Opinion Rheumatol. 1998, 10: 459-467.CrossRef

16.

Lehman T, McCurdy DK, Bernstein BH, King KK, Hanson V: Systemic lupus erythematosus in the first decade of life. Pediatrics. 1989, 83: 235-239.PubMed

17.

Lehman TJ: A practical guide to systemic lupus erythematosus. Pediatr Clin N Amer. 1995, 42: 1223-1238.CrossRef

18.

Jarvis JN: Juvenile rheumatoid arthritis: a guide for pediatricians. Pediatr Ann. 2002, 31: 437-446.CrossRefPubMed

19.

Feldman BM, Reichlin M, Laxer RM, Targoff IN, Stein LD, Silverman ED: Clinical significance of specific autoantibodies in juvenile dermatomyositis. J Rheumatol. 1996, 23: 1794-1797.PubMed

20.

Rennenbohm R: Juvenile dermatomyositis. Pediatr Ann. 2002, 31: 426-433.CrossRef

21.

Cabral D, Tucker L: Malignancies in children who initially present with rheumatic complaints. J Pediatr. 1999, 134: 53-57.CrossRefPubMed

22.

Saulsbury FT, Sabio H: Acute leukemia presenting as arthritis in children. Clin Pediat. 1985, 24: 625-628.CrossRefPubMed

The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2431/4/13/prepub

Title: Clinical utility of antinuclear antibody tests in children
Authors: Julie L McGhee
Lauren M Kickingbird
James N Jarvis
Publication date: 01-12-2004
Publisher: BioMed Central
Published in: BMC Pediatrics / Issue 1/2004
Electronic ISSN: 1471-2431
DOI: https://doi.org/10.1186/1471-2431-4-13

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Clinical utility of antinuclear antibody tests in children

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2004

Parents' reported preference scores for childhood atopic dermatitis disease states

Human Cytomegalovirus: detection of congenital and perinatal infection in Argentina

Infant mortality trends in a region of Belarus, 1980–2000

Lactobacillus caseistrain GG in the treatment of infants with acute watery diarrhea: A randomized, double-blind, placebo controlled clinical trial [ISRCTN67363048]

Low birth weight and longitudinal trends of cardiovascular risk factor variables from childhood to adolescence: the bogalusa heart study

Does routine child health surveillance contribute to the early detection of children with pervasive developmental disorders? – An epidemiological study in Kent, U.K.